Key result
Intravenous dexmedetomidine infusion significantly lowered postoperative levels of interleukin-6, cortisol, blood glucose, and pain scores compared to placebo in major abdominal surgery.
Why the study?
Does intravenous dexmedetomidine infusion reduce stress response markers and postoperative pain in adult patients undergoing major abdominal surgery?
RCT (n=30)
Randomly classified
No
Does intravenous dexmedetomidine infusion reduce stress response markers and postoperative pain in adult patients undergoing major abdominal surgery?
Intravenous dexmedetomidine during major abdominal surgery effectively blunts the postoperative stress response and reduces pain without significantly delaying recovery.
This is the authors' abstract. We don't add key points for this paper.
BackgroundThis study was designed to evaluate the effect of intravenous dexmedetomidine infusion in patients undergoing major abdominal surgery on stress response markers as plasma interleukin-6, cortisol and blood glucose level. It also assessed its effect on recovery profile and postoperative pain.MethodsThirty adult ASA I–III patients admitted to the surgery department of the Alexandria Main University Hospital scheduled for elective major abdominal surgery under general anaesthesia were included. They were randomly classified into two equal groups of 15 patients each, dexmedetomidine group (Group D) received intravenous dexmedetomidine infusion and placebo group (Group P) received intravenous infusion of normal saline. Haemodynamic parameters were recorded intra- and postoperatively. Interleukin-6, cortisol and blood glucose levels were measured. Recovery profile, postoperative pain score and analgesic requirement postoperatively were assessed.ResultsHeart rate and mean arterial pressure were significantly lower in group D relative to group P during most of the intra- and postoperative periods. Postoperatively, the levels of interleukin-6, cortisol and blood glucose were significantly lower in group D relative to group P. Recovery time was longer in group D than group P but with no significant difference. Postoperative pain score was significantly less in group D relative to group P during the early postoperative period with smaller amount of analgesic requirements in group D.ConclusionDexmedetomidine is safe and effective in blunting the postoperative rise of the proinflammatory cytokine interleukin-6 and resulted in lower levels of markers of stress response to surgery as cortisol and blood glucose. Dexmedetomidine also reduces the postoperative pain score without delaying recovery from anaesthesia.
Answers are grounded in this paper and cite their sources.
Supports dexmedetomidine infusion to reduce postoperative stress and pain in major abdominal surgery; confirms RCT benefits on inflammatory markers.
No takes yet. Share an insight, caveat, or question.
Yacout et al. (2011) conducted an RCT in Elective major abdominal surgery (n=30). Intravenous dexmedetomidine infusion vs. Intravenous infusion of normal saline (placebo) was evaluated on Stress response markers (plasma interleukin-6, cortisol and blood glucose level). Intravenous dexmedetomidine infusion significantly lowered postoperative levels of interleukin-6, cortisol, blood glucose, and pain scores compared to placebo in major abdominal surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: